Laboratorios Farmaceuticos Rovi SA 2016 AR2
The report highlights Laboratorios Farmaceuticos Rovi's financial and ESG performance for the fiscal year 2016. The company achieved record financial results, with operating revenue growing by 8% to 265.2 million euros and net profit increasing by 32% to 26.1 million euros. On the sustainability front, ROVI expanded its workforce to 1,150 employees, maintained a strong focus on equal opportunities, and significantly increased its training hours. Additionally, the company doubled its environmental expenses to over 680,000 euros, focusing on waste management and energy efficiency improvements across its manufacturing plants.
Company: Laboratorios Farmaceuticos Rovi SA
Sector: Manufacturing
Country: Spain
Year: 2016
Type: AR2
Pages: 112
Laboratorios Farmaceuticos Rovi SA
The report highlights Laboratorios Farmaceuticos Rovi's financial and ESG performance for the fiscal year 2016. The company achieved record financial results, with operating revenue growing by 8% to 265.2 million euros and net profit increasing by 32% to 26.1 million euros. On the sustainability front, ROVI expanded its workforce to 1,150 employees, maintained a strong focus on equal opportunities, and significantly increased its training hours. Additionally, the company doubled its environmental expenses to over 680,000 euros, focusing on waste management and energy efficiency improvements across its manufacturing plants.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Total Waste
Women in Management
Employees